A Pennsylvania appellate judge wondered during oral argument Tuesday what the "breaking point" is for a drug manufacturer facing 1,000 Philadelphia lawsuits where plaintiffs are seeking punitive damages based on the same evidence of alleged wrongdoing.
Superior Court Judge Kate Ford Elliott said that the same evidence on punitive damages will need to be presented in 1,000 drug products liability cases pending in Philadelphia Common Pleas Court against Pfizer on injuries allegedly caused by two of its divisions’ hormone-replacement therapy drugs. Women are suing two of Pfizer’s divisions, which have merged into the drug company, on the theory that their use of hormone-replacement therapy caused their breast cancer.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
